NPPA slashes prices of HIV, diabetes, angina drugs

The national drug pricing regulator National Pharmaceutical Pricing Authority (NPPA) has capped prices of over 50 essential drugs. It has led to a price cut in the range of 5 to 44% with the average being about 25%. These 50 drugs include those used for treatment of HIV infection, diabetes, anxiety disorders, bacterial infections, angina and acid reflux. Besides, NPPA has also fixed the retail prices of 29 formulations. In this regard in has. These 55 scheduled drug formulations and retail prices are regulated under the Schedule-I of the Drugs (Price Control) Amendment Order, 2016 by the NPPA.